Docosapentaenoic acid (22n-3)
Based on 1 Customer Validation
Docosapentaenoic acid (22n-3) is a component of phospholipids. Docosapentaenoic acid 22n-3 has inhibitory activity against α-amylase and α-glucosidase, with IC50s value of 17 μg/mL and 22 μg/mL, respectively. Docosapentaenoic acid 22n-3 increases cell vitality. Docosapentaenoic acid 22n-3 has a weak anti-inflammatory effect.
For research use only. We do not sell to patients.
- Purity: 99.87%
- CAS No.: 24880-45-3
- Formula: C22H34O2
- Molecular Weight:330.50
-
Storage:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
HY-B2167
Docosahexaenoic acid
-
HY-N0729
Linoleic acid
-
HY-B0660
Eicosapentaenoic Acid
-
HY-B2167R
Docosahexaenoic acid (Standard)
-
HY-109590
Arachidonic acid
-
HY-W013215
Adrenic acid
-
HY-A0143
Dihomo-γ-linolenic acid
-
HY-N0728
α-Linolenic acid
-
HY-W013242
Gondoic acid
-
HY-N7109
Erucic acid
-
HY-101408
Docosatrienoic Acid
-
HY-N2041
Myristic acid
Biological Activity
|
α‑glucosidase 22 μg/mL (IC50) |
Docosapentaenoic acid 22n-3 (50-100 μM; 24 h) increases vitality of bone marrow-derived stem cells (BMSCs)[2].
Docosapentaenoic acid 22n-3 has inhibitory activity against α-amylase and α-glucosidase, with IC50s value of 17 μg/mL and 22 μg/mL, respectively[3].
Docosapentaenoic acid 22n-3 (16 μg/mL) has a weaker anti-inflammatory effect than Phenylalanine[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 24880-45-3
-
Appearance Liquid (Density: 0.932±0.06 g/cm3)
-
Molecular Weight 330.50
-
Formula C22H34O2
-
Color Colorless to light yellow
-
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(O)=O
-
Synonyms
Clupanodonic acid
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : 50 mg/mL (151.29 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 2.5 mg/mL (7.56 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.5 mg/mL (7.56 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (266 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.0257 mL | 15.1286 mL | 30.2572 mL | 75.6430 mL |
| 5 mM | 0.6051 mL | 3.0257 mL | 6.0514 mL | 15.1286 mL | |
| 10 mM | 0.3026 mL | 1.5129 mL | 3.0257 mL | 7.5643 mL | |
| 15 mM | 0.2017 mL | 1.0086 mL | 2.0171 mL | 5.0429 mL | |
| 20 mM | 0.1513 mL | 0.7564 mL | 1.5129 mL | 3.7821 mL | |
| 25 mM | 0.1210 mL | 0.6051 mL | 1.2103 mL | 3.0257 mL | |
| 30 mM | 0.1009 mL | 0.5043 mL | 1.0086 mL | 2.5214 mL | |
| 40 mM | 0.0756 mL | 0.3782 mL | 0.7564 mL | 1.8911 mL | |
| 50 mM | 0.0605 mL | 0.3026 mL | 0.6051 mL | 1.5129 mL | |
| 60 mM | 0.0504 mL | 0.2521 mL | 0.5043 mL | 1.2607 mL | |
| 80 mM | 0.0378 mL | 0.1891 mL | 0.3782 mL | 0.9455 mL | |
| 100 mM | 0.0303 mL | 0.1513 mL | 0.3026 mL | 0.7564 mL |
Docosapentaenoic acid (22n-3) Related Classifications
HY-113159 Related Classifications
Powered by Bioz